Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High Expression of p62 Protein Is Associated with Poor Prognosis and Aggressive Phenotypes in Endometrial Cancer.

The American journal of pathology - 1 Sept 2015

Iwadate Reiko, Inoue Jun, Tsuda Hitoshi, Takano Masashi, Furuya Kenichi, Hirasawa Akira, Aoki Daisuke, Inazawa Johji

Abstract excerpt

High expression of SQSTM1/p62 (p62) protein, which functions as a hub of oncogenic signaling pathways, has been detected in several human cancers. However, the clinicopathological and functional contribution of p62 expression is largely unknown in endometrial cancers (ECs). In this study, we assessed the expression status of p62 in primary ECs (n = 194) by immunohistochemistry and analyzed its clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adaptor Proteins, Signal Transducing
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Heat-Shock Proteins

Share to Mice, Nude

Share to RNA-Binding Proteins

Share to RNA Interference

Share to Sequestosome-1 Protein

Source

Identifiers

PMID: 26162509
DOI: 10.1016/j.ajpath.2015.05.008

Genes

SQSTM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

High Expression of p62 Protein Is Associated with Poor Prognosis and Aggressive Phenotypes in Endometrial Cancer.PMID 26162509Read ↗

Cytoplasmic SQSTM1/ P62 Accumulation Predicates a Poor Prognosis in Patients with Malignant TumorSemantic proximity Read ↗

Proteomic Analysis of Low-Grade, Early-Stage Endometrial Carcinoma Reveals New Dysregulated Pathways Associated with Cell Death and Cell SignalingSemantic proximity Read ↗

p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasisSemantic proximity Read ↗

A Crucial Interaction of p62 and Nrf2 in Mediating Metastasis of Esophageal Squamous Cell CancerSemantic proximity Read ↗

An HMGA2‐p62‐ERα axis regulates uterine leiomyomas proliferationSemantic proximity Read ↗

An Alternatively Spliced p62 Isoform Confers Resistance to Chemotherapy in Breast CancerSemantic proximity Read ↗

Phenotypic characterization of endometrial stromal sarcoma of the uterus.Semantic proximity Read ↗

Endometrial carcinomas with dyshesive, eosinophilic, and vacuolated (histiocyte-like) tumor cells: a reactive-like phenotype associated with aggressive behavior.Semantic proximity Read ↗

Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis.Semantic proximity Read ↗

Distinctive p53 and mdm2 Immunohistochemical Expression Profiles Suggest Different Pathogenetic Pathways in Poorly Differentiated Endometrial CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.